The revised contract would allow the EU to upgrade to newer vaccines tailored to any future COVID-19 variants, the report added
PHOTO
Pfizer Inc and BioNTech's new proposal with the European Union includes a provision for member states to pay half price, or about 10 euros ($11), for each of about 70 million cancelled COVID-19 doses, the Financial Times reported on Sunday.
The revised contract would allow the EU to upgrade to newer vaccines tailored to any future COVID-19 variants, the report added, citing people close to negotiations. ($1 = 0.9074 euros)
(Reporting by Urvi Dugar in Bengaluru; Editing by Lincoln Feast)
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
